Eur Rev Med Pharmacol Sci 2022; 26 (24): 9416-9425
DOI: 10.26355/eurrev_202212_30693

Analysis of clinical features, treatment, and prognosis of primary Xlymphoepithelioma-like carcinoma of the lung

H.-Y. Hu, L. Long, S.-A. Dai, G.-Q. Yan, Y. Huang, J. He

State Key Laboratory of Biotherapy, Lung Cancer Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China. he-001jun@163.com


OBJECTIVE: Primary pulmonary lymphoepithelioma-like carcinoma (PPLELC) is a rare lung malignancy occurring most frequently in young non-smokers from Southeast Asia. Given its low incidence, PPLELC clinical features, treatment methods, and the factors affecting its prognosis remain elusive. To date, PPLELC data are mainly derived from clinical case reports, and no cohort studies are available. Therefore, we retrospectively analyzed a group of PPLELC cases and summarized the clinical features of patients, treatment responses, and the factors affecting patient prognosis.

PATIENTS AND METHODS: A total of 91 patients having primary pulmonary lymphoepithelioma-like carcinoma were recruited in this study. These included sex, age, place of birth, smoking history, pre-treatment symptoms, tumor location, tumor markers, maximum tumor diameter, treatment regimen, lymph node presence metastasis after an operation, pathological picture, immunohistochemistry, genetic findings, and tumor stage grading. We determined the overall survival (OS), progression-free survival (PFS), basic clinical characteristics, treatment option, treatment response, and recurrence pattern among the patients. In addition, we understood the influence of sex, age, tumor, nodes, and metastases (TNM) stage, tumor size, and surgery over patient prognosis.

RESULTS: Primary pulmonary lymphoepithelioma-like carcinoma is more common among young non-smokers, with a slightly higher incidence in women than in men. The expression of Epstein-Barr virus-encoded small RNA (EBER), pancytokeratin (PCK), Cytokeratin 5/6 (CK5/6), and tumor protein 63 (P63) was positive in immunohistochemistry. Serum cytokeratin 19 fragment antigen (CYFRA21-1) and Epstein-Barr DNA (EB-DNA) could be used as markers to diagnose primary pulmonary lymphoepithelioma-like carcinoma. TNM stage and surgery were independent prognostic factors.

CONCLUSIONS: Primary pulmonary lymphoepithelioma-like carcinoma is rare, showing a good prognosis.

Free PDF Download

To cite this article

H.-Y. Hu, L. Long, S.-A. Dai, G.-Q. Yan, Y. Huang, J. He
Analysis of clinical features, treatment, and prognosis of primary Xlymphoepithelioma-like carcinoma of the lung

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 24
Pages: 9416-9425
DOI: 10.26355/eurrev_202212_30693